As of 2015, Xenex is not available for trade on the stock market for investors, according to Bloomberg. The company only has filings that include a Notice of Exempt Offering of Securities, indicates the U.S. Securities and Exchange Commission.
Xenex sells products to health care facilities that help minimize micro-organisms, reports Bloomberg. Health care staff use these products in such places as patients’ rooms and operating rooms. Xenex obtained over $11 million in funding for product development.
If a company goes public, it must qualify for listing on a stock exchange such as NASDAQ and file a prospectus with the SEC, explains Inc. This filing immediately becomes available to the public and the company's estimated price for each share is listed on the NASDAQ.